89 related articles for article (PubMed ID: 1234062)
1. The role of thymus on autosensitization against syngeneic normal and malignant cells.
Carnaud C; Ilfeld D; Petranyi G; Klein E
Eur J Immunol; 1975 Aug; 5(8):575-9. PubMed ID: 1234062
[TBL] [Abstract][Full Text] [Related]
2. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
Lespinats G; Poupon MF
Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
Treves AJ; Schechter B; Cohen IR; Feldman M
J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of in vitro autosensitization by a thymic humoral factor.
Trainin N; Carnaud C; Ilfeld D
Nat New Biol; 1973 Oct; 245(147):253-5. PubMed ID: 4518370
[No Abstract] [Full Text] [Related]
5. In vitro sensitization and induction of syngeneic tumor--specific cell--mediated cytotoxicity.
Ferguson RM; Moe M; Simmons RL
Surg Forum; 1976; 27(62):117-9. PubMed ID: 1032910
[No Abstract] [Full Text] [Related]
6. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
Konda S; Smith RT
Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
[No Abstract] [Full Text] [Related]
7. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
8. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
Taniguchi K; Gondo H; Nomoto K
J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
[TBL] [Abstract][Full Text] [Related]
9. A model for the autosensitization autoantibody production associated with xenogeneic thymic RNA.
Nakamura K; Nakamura Y; Kawahara M
J Immunol; 1978 Aug; 121(2):702-9. PubMed ID: 355551
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor.
Small M; Trainin N
Int J Cancer; 1975 Jun; 15(6):962-72. PubMed ID: 1150350
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
[TBL] [Abstract][Full Text] [Related]
12. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.
Stutman O; Paige CJ; Figarella EF
J Immunol; 1978 Nov; 121(5):1819-26. PubMed ID: 712067
[No Abstract] [Full Text] [Related]
13. Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes.
Lonai P; Mogilner B; Rotter V; Trainin N
Eur J Immunol; 1973 Jan; 3(1):21-6. PubMed ID: 4146225
[No Abstract] [Full Text] [Related]
14. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
[TBL] [Abstract][Full Text] [Related]
15. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.
Röllinghoff M; Wagner H
Eur J Immunol; 1973 Aug; 3(8):471-6. PubMed ID: 4543174
[No Abstract] [Full Text] [Related]
16. The role of antigen load in tumor- specific immunity.
Burk MW; Ristow SS; McKhann CF
Surg Forum; 1974; 25(0):107-8. PubMed ID: 4439133
[No Abstract] [Full Text] [Related]
17. Destruction of experimental malignant melanoma by mediators of cellular immunity.
Youdim S
Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
19. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
Eggers AE; Wunderlich JR
J Immunol; 1975 May; 114(5):1554-6. PubMed ID: 123545
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-mediated cytotoxicity: effects of ageing, adult thymectomy and thymic factor.
Bach MA
J Immunol; 1977 Aug; 119(2):641-7. PubMed ID: 142115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
